Name Of Drug Edited One

LADABAN, FRIEDA R. Group 22

4-6

NAME of DRUG

ACTION/KINET ICS

CONTRAINDICAT IONS

SPECIAL CONCERNS

Brand name:

Tab symptomatic relief of anxiety, agitation & tension due to psychoneurotic states & transient situational disturbances.

Dependence onother substances including alcohol except in management of acute withdrawal reactions. Severe chronic hypercapnia.

Cardioresp insufficiency; pregnancy, lactation;myasth eniagravis. May modify psychomotor performances. Dependence, w/drawal symptoms.

Relief of moderate to severe pain. Pre-op analgesia, as a supplement to balanced anesth, surgical

Impaired renal or hepatic function, biliary tract surgery, impaired respiration, MI. Labour & delivery.

VALIUM Generic name:

Diazepam Dosage:

Tab Adult 5-20 mg daily. Elderly Half the usual adult dose. Children 0.1-0.3 mg/kg body wt daily.

Brand name:

Nubain Preservative Free Generic name:

Nalbuphine HCl

SIDE EFFECTS

DRUG INTERACTIONS Sedative effects intensified by other centrally-acting drugs. Alcohol (avoid)

Sedation, infrequently sweating, GI upsets, vertigo, dizziness; dry mouth; headache,

Phenothiazines; alcohol, CNS depressants

NURSING CONSIDERATION

Dosage:

Adult 0.150.2 mg/kg body wt. Children 0.1-0.2 mg/kg up to a total single dose of 10 mg SC, IMor IV. May be repeated 3-6 hrly as needed. Brand name:

KETANOV Generic name:

Ketorolac tromethamin e Tab 10 mg 4-6 hrly Max: 40 mg/day. Dosage:

anaesth, for obstet analgesia during labor & relief of pain following MI. Post-op somatic & visceral pain.

Short term management of moderate to severe acute pain.

allergic reactions.

Asthma, hypovolemia, dehydration, history of peptic ulcer or coagulation disease, hypersensitivity to NSAIDs, aspirin, prostaglandin synthesis inhibitors, anaphylaxis, complete or partial syndrome of nasal polyps, angioedema or bronchospasm, moderate to severe renal

Active hepatitis or cholestasis, conditions predisposing to GI toxicity eg active alcoholism or inflammatory bowel disease of tobacco use,conditions predisposing to & or exacerbated by fluid retention eg compromised cardiac function, CHD, preexisting edema, HTN or sepsis. Renal function

Bronchospas m, dyspnea, itching & rash. Flatulence, indigestion, nausea & diarrhea. GI ulceration, bleeding & perforation may occur on long-term use. Drowsiness, dizziness, headache, aseptic meningitis, convulsion, hallucination,

Lithium salts, other NSAIDs, pentoxifylline, probenecid, anticoagulants. Antihypertensive & diuretics. Alcohol, corticosteroid, potassium supplement, acetaminophen. Cefamandole, cefoperazone, cefotetan, valproicacid. Methotrxate

impairment, suspected or confirmed GI bleeding & or cerebrovascular bleeding, hemorrhagic diathesis, high risk or incomplete hemostasis. Pregnancy, labor, lactation.

impairment. Elderly

& hearing loss. Inhibition of platelet aggregation, thrombocyto penia & anemia. Flank pain, fluid retention, oliguria, azotemia, nephritis, Rash & exfoliative dermatitis

SIDE EFFECTS

DRUG INTERACTIONS

Occasionally GI disorders, headache, dizziness, vertigo, rash, elevation of serum transaminas

Increases plasma conc of lithium, methotrexate, digoxin. May reduce effects of diuretics. Anticoagulants, oral antidiabetics,

NAME of DRUG

ACTION/KINET ICS

CONTRAINDICAT IONS

SPECIAL CONCERNS

Brand name:

Short-term treatment of post- traumatic & post-op pain & inflammation, dysmenorrhea, migraine

Known hypersensitivity to diclofenac or other NSAIDs, gastric or intestinal ulcer.

Symptoms/histo ry of GI disease, asthma, impaired hepatic, cardiac or renal function. Porphyria.

CATAFLAM Generic name:

DICLOFENAC Dosage:

NURSING CONSIDERATION

Adult 50150 mg/day individual. Dysmenorr hea & migraine attacks Up to 200 mg/day. Children > 1 yr 0.5-2 mg/kg/day. All doses to be given daily in 2-3 divided doses.

attacks, adnexitis & non-articular rheumatism; ENT infections.

Elderly. CNS disturbances can influence the ability to drive & use machine. Extracellular voldepletion. Pregnancy & lactation. In prolonged treatment, periodic monitoring of liver function & blood counts recommended NSAIDs may mask infection or temporarily inhibit platelet aggregation.

es. Rarely, gastric or intestinal ulcer, abnormalitie s of renal function, GI bleeding, hepatitis, hypersensitiv ity. Isolated cases: Diaphragmlike intestinal strictures, aseptic meningitis, erythema multiforme, CV disturbances, disturbance of sensation or vision, purpura, blood dyscrasias, Lyell’s syndrome, StevensJohnson syndrome, pancreatitis, pnuemonitis, erythroderm a.

ciclosporin, quinolones, other NSAIDs.

NAME of DRUG

ACTION/KINET ICS

CONTRAINDICAT IONS

SPECIAL CONCERNS

Brand name:

Local or regional anesthfor local infiltration, peripheral nerve blocks, IV nerve blocks. Treatment of ventricular arrhythmias cause by acute MI, open heart surgery & digitalis.

Uncorrected hypotension, infection or inflammation in the area of inj. Hypersensitivity to lidocaine.

Severe liver & kidney disease. Hypovolemia, heart block, CHF, bradycardia & respdepression. Elderly, debilitated, children.

EURO-MED LIDOCAINE HCl Generic name:

LIDOCAINE HCl Dosage:

Local/regio nal anesthIndivi dualize dosage. Antiarrhyt mic 0.7-1.4 mg/kg body wt IV, or 1-4 mg/min IV infusion or 45 mg/kg body wt IM. Max dose: 200 mg given within 1 hour period.

SIDE EFFECTS Mild drowsiness w/ parethesias, agitation, disorientatio n, muscle twitching, frank convulsion & resparrest. Bradycardia, hypotension, CV collapse & cardiac arrest.

DRUG INTERACTIONS Additive effect with other arrythmics.

NURSING CONSIDERATION